decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / GAMMA_GLUTAMYL_TRANSFERASE
Subscribe or sign in to view the full article.
Article Overview
This National Coverage Determinations Manual article covers Medicare guidance for gamma glutamyl transferase (GGT) laboratory testing. It explains the general clinical context for the test, the types of liver-related and hepatobiliary situations addressed by the coverage policy, and the limitations on repeating or using the test. The article is relevant to laboratory billing, medical coding, and compliance professionals who need to understand when the service is addressed under coverage policy.
Why This Topic Matters
GGT testing is commonly used in liver-related evaluation, and coverage policies affect whether the service is considered medically appropriate in different clinical contexts. Understanding the scope of the manual entry helps coding and billing staff support compliant test reporting and document medical necessity appropriately.
What You Will Learn
- The clinical purpose of gamma glutamyl transferase testing in hepatobiliary assessment
- The general categories of indications addressed by the coverage policy
- The kinds of situations where repeat testing is limited or not generally necessary
- How the article frames the role of GGT in liver-related evaluation and follow-up
Who Should Read This
- Medical coders
- Billing specialists
- Compliance staff
- Laboratory managers
- Clinicians ordering laboratory tests
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com